Related Experiment Video
Updated: May 20, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Overdose of pegfilgrastim: case report
Gisela Riu1, Anna Estefanell, Meritxell Nomdedeu
1Pharmacy Service, Hospital Clínic de Barcelona, c/Villarroel, 170, Escalera 8 sótano, 08036 Barcelona, Spain. gisbcn@hotmail.com
Background:
Pegfilgrastim is a G-CSF that can be administered in a single dose 24 h after each cycle of chemotherapy.
Case:
59 years-old man with a stage III-B peripheral T lymphoma with CD4 expression. Dose-dense chemotherapy was started with CHOP-14 combined with pegfilgrastim as primary prophylaxis. An error in the dispensing system meant that the patient received pegfilgrastim for 4 consecutive days. He remained under observation in hospital. During the 3 days after the last dose of pegfilgrastim, the patient remained stable, with no remarkable symptoms or associated laboratory abnormalities, and was discharged.
Conclusion:
The case we describe and the available literature lead us to suggest close monitoring as the main measure to be adopted when treating a patient for pegfilgrastim overdose.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Toxicity: Risk factors
Drug Toxicity: Overview
Pharmaceutical Poisoning: Potential Scenarios